1XZ:F:F-Ping An Healthcare and Technology Company Ltd (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 1.0985

Change

+0.02 (+1.57)%

Market Cap

USD 1.21B

Volume

67.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Ping An Healthcare and Technology Company Limited, together with its subsidiaries, operates an online healthcare services platform in China. It offers online medical services, such as online consultation, hospital referral and appointment, inpatient arrangement, and second opinion services; prepaid cards and health check-up services; and medical devices. The company also provides advertising, wellness management, and health management services. In addition, it provides medicine marketing services; technology services; application development and operation services; and hospital and clinic services, as well as operates an insurance agency. The company was incorporated in 2014 and is headquartered in Shanghai, China.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

+1.53 (+1.93%)

USD 35.91B
2HE:F Healthequity Inc

-1.00 (-1.42%)

USD 6.16B
4YC:F M3 INC.

+0.10 (+1.15%)

USD 5.81B
6HL0:F R1 RCM Inc

+0.10 (+0.79%)

USD 5.45B
9EH:F Evolent Health Inc

+0.40 (+1.46%)

USD 3.16B
1KJ:F 10X GENOMICS DL -00001

+2.23 (+11.83%)

USD 2.31B
6JM:F JMDC INC.

N/A

USD 1.93B
OC9:F Omnicell Inc

-1.80 (-4.50%)

USD 1.78B
19P:F Phreesia Inc

-0.20 (-0.92%)

USD 1.26B
4LL:F Teladoc Inc

+0.05 (+0.60%)

USD 1.25B

ETFs Containing 1XZ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -45.02% 24% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.02% 24% F 10% F
Trailing 12 Months  
Capital Gain -47.49% 36% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -47.49% 34% F 13% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -32.82% 5% F 2% F
Dividend Return -32.82% 5% F 2% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 27.54% 50% F 47% F
Risk Adjusted Return -119.19% 3% F 1% F
Market Capitalization 1.21B 84% B 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector